Skip to content
The Nexus
DossierENTITY

spatial biology

Coverage of spatial biology in the Nexus archive.

Earliest in view: Jun 16 · 08:30 UTCMost recent: Jun 26 · 14:20 UTC
Co-mentioned in this coverage
Merck KGaAorganization1Bio-Techneorganization1Sigma-Aldrichorganization1proteinstopic1cell and gene therapytopic1International Human Cell Atlas Consortiumorganization1Aviv Regevperson1David Altshulerperson1Eric Landerperson110x Genomicsorganization1Vizgenorganization1Illuminaorganization1
Recent coverage
  • BUSINESSJun 26 · 14:20 UTCQUARTZ
    Germany's Merck KGaA is buying lab-tools supplier Bio-Techne for $11.3 billion

    Germany's Merck KGaA is acquiring lab-tools supplier Bio-Techne for $11.3 billion, marking its largest deal since the Sigma-Aldrich buyout. The acquisition expands Merck's presence in proteins, spatial biology, and cell and gene therapy.

  • SCIENCEJun 16 · 08:30 UTCSTAT NEWS
    STAT+: Human Cell Atlas leader’s tie to 10x Genomics raises conflict-of-interest questions

    The International Human Cell Atlas Consortium is hosting a major meeting in Boston, featuring leaders like Aviv Regev and Eric Lander, as it advances toward publishing its first draft of a comprehensive human cell map. The project faces potential conflict-of-interest concerns due to its reliance on 10x Genomics' technology, which is now competing with other emerging spatial biology tools from companies like Vizgen and Illumina.